Localization of asv integrase-dna contacts by site-directed crosslinking and their structural analysis

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Peletskaya, Elena ^a   Andrake, Mark ^b   Gustchina, Alla ^c   Merkel, George ^b   Alexandratos, Jerry ^c   Zhou, Dongwen ^c   Bojja, Ravi S ^b   Satoh, Tadashi ^c   Potapov, Mikhail ^d   Kogon, Alex ^a   Potapov, Viktor ^d   Wlodawer, Alexander ^c   Skalka, Anna Marie ^b  

^a Biolinx LLC   (United States)

^b FOX CHASE CANCER CENTER   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d SHEMYAKIN OVCHINNIKOV INSTITUTE OF BIOORGANIC CHEMISTRY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; INTEGRASE; NUCLEOTIDE; PHOSPHATE; THIOL DERIVATIVE; VIRUS DNA; CROSS LINKING REAGENT;

AMINO TERMINAL SEQUENCE; ARTICLE; AVIAN SARCOMA VIRUS; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; CRYSTAL STRUCTURE; CRYSTALLOGRAPHY; DNA CROSS LINKING; DNA MODIFICATION; DNA STRAND; DNA STRUCTURE; ENZYME LOCALIZATION; ENZYME SUBSTRATE; NONHUMAN; PHOTOAFFINITY LABELING; PROTEIN DNA BINDING; SPUMA VIRUS; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; AMINO ACID SEQUENCE; BINDING SITE; CHEMICAL MODEL; CHEMICAL STRUCTURE; CHEMISTRY; ENZYMOLOGY; GENETICS; LIGHT; MASS SPECTROMETRY; METABOLISM; MOLECULAR GENETICS; MUTATION; NUCLEOTIDE SEQUENCE; PROTEIN CONFORMATION; SEQUENCE HOMOLOGY; SITE DIRECTED MUTAGENESIS; X RAY CRYSTALLOGRAPHY;

AMINO ACID SEQUENCE; AVIAN SARCOMA VIRUSES; BASE SEQUENCE; BINDING SITES; CROSS-LINKING REAGENTS; CRYSTALLOGRAPHY, X-RAY; DNA, VIRAL; INTEGRASES; LIGHT; MODELS, CHEMICAL; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; MUTATION; PROTEIN CONFORMATION; SEQUENCE HOMOLOGY, AMINO ACID; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 82455186329     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0027751     Document Type: Article

References (55)

1. Pommier Y, Pilon AA, Bajaj K, Mazumder A, Neamati N, (1997) HIV-1 integrase as a target for antiviral drugs. Antivir Chem Chemother 8: 463-483.
2. Jaskolski M, Alexandratos JN, Bujacz G, Wlodawer A, (2009) Piecing together the structure of retroviral integrase, an important target in AIDS therapy. FEBS J 276: 2926-2946.
3. Prada N, Markowitz M, (2010) Novel integrase inhibitors for HIV. Expert Opin Investig Drugs 19: 1087-1098.
4. Powderly WG, (2010) Integrase inhibitors in the treatment of HIV-1 infection. J Antimicrob Chemother 65: 2485-2488.
5. Al-Mawsawi LQ, Neamati N, (2011) Allosteric inhibitor development targeting HIV-1 integrase. ChemMedChem 6: 228-241.
6. Maertens GN, Hare S, Cherepanov P, (2010) The mechanism of retroviral integration from X-ray structures of its key intermediates. Nature 468: 326-329.
7. Krishnan L, Li X, Naraharisetty HL, Hare S, Cherepanov P, Engelman A, (2010) Structure-based modeling of the functional HIV-1 intasome and its inhibition. Proc Natl Acad Sci USA 107: 15910-15915.
8. Asante-Appiah E, Skalka AM, (1997) A metal-induced conformational change and activation of HIV-1 integrase. J Biol Chem 272: 16196-16205.
9. Asante-Appiah E, Seeholzer SH, Skalka AM, (1998) Structural determinants of metal-induced conformational changes in HIV-1 integrase. J Biol Chem 273: 35078-35087.
10. Rice P, Mizuuchi K, (1995) Structure of the bacteriophage Mu transposase core: A common structural motif for DNA transposition and retroviral integration. Cell 82: 209-220.
11. Davies DR, Goryshin IY, Reznikoff WS, Rayment I, (2000) Three-dimensional structure of the Tn5 synaptic complex transposition intermediate. Science 289: 77-85.
12. Hare S, Gupta SS, Valkov E, Engelman A, Cherepanov P, (2010) Retroviral intasome assembly and inhibition of DNA strand transfer. Nature 464: 232-236.
13. Jenkins TM, Esposito D, Engelman A, Craigie R, (1997) Critical contacts between HIV-1 integrase and viral DNA identified by structure-based analysis and photo-crosslinking. EMBO J 16: 6849-6859.
14. Esposito D, Craigie R, (1998) Sequence specificity of viral end DNA binding by HIV-1 integrase reveals critical regions for protein-DNA interaction. EMBO J 17: 5832-5843.
15. Heuer TS, Brown PO, (1997) Mapping features of HIV-1 integrase near selected sites on viral and target DNA molecules in an active enzyme-DNA complex by photo- cross-linking. Biochemistry 36: 10655-10665.
16. Heuer TS, Brown PO, (1998) Photo-cross-linking studies suggest a model for the architecture of an active human immunodeficiency virus type 1 integrase-DNA complex. Biochemistry 37: 6667-6678.
17. Peletskaya EN, Boyer PL, Kogon AA, Clark P, Kroth H, et al. (2001) Cross-linking of the fingers subdomain of human immunodeficiency virus type 1 reverse transcriptase to template-primer. J Virol 75: 9435-9445.
18. Peletskaya EN, Kogon AA, Tuske S, Arnold E, Hughes SH, (2004) Nonnucleoside inhibitor binding affects the interactions of the fingers subdomain of human immunodeficiency yirus type 1 reverse transcriptase with DNA. J Virol 78: 3387-3397.
19. Gao K, Butler SL, Bushman F, (2001) Human immunodeficiency virus type 1 integrase: arrangement of protein domains in active cDNA complexes. EMBO J 20: 3565-3576.
20. Lutzke RA, Vink C, Plasterk RH, (1994) Characterization of the minimal DNA-binding domain of the HIV integrase protein. Nucleic Acids Res 22: 4125-4131.
21. Chen A, Weber IT, Harrison RW, Leis J, (2006) Identification of amino acids in HIV-1 and avian sarcoma virus integrase subsites required for specific recognition of the long terminal repeat Ends. J Biol Chem 281: 4173-4182.
22. Dolan J, Chen A, Weber IT, Harrison RW, Leis J, (2009) Defining the DNA substrate binding sites on HIV-1 integrase. J Mol Biol 385: 568-579.
23. Chen JC, Krucinski J, Miercke LJ, Finer-Moore JS, Tang AH, et al. (2000) Crystal structure of the HIV-1 integrase catalytic core and C-terminal domains: a model for viral DNA binding. Proc Natl Acad Sci USA 97: 8233-8238.
24. Chen Z, Yan Y, Munshi S, Li Y, Zugay-Murphy J, et al. (2000) X-ray structure of simian immunodeficiency virus integrase containing the core and C-terminal domain (residues 50-293)-an initial glance of the viral DNA binding platform. J Mol Biol 296: 521-533.
25. Yang ZN, Mueser TC, Bushman FD, Hyde CC, (2000) Crystal structure of an active two-domain derivative of Rous sarcoma virus integrase. J Mol Biol 296: 535-548.
26. Wang JY, Ling H, Yang W, Craigie R, (2001) Structure of a two-domain fragment of HIV-1 integrase: implications for domain organization in the intact protein. EMBO J 20: 7333-7343.
27. Alian A, Griner SL, Chiang V, Tsiang M, Jones G, et al. (2009) Catalytically-active complex of HIV-1 integrase with a viral DNA substrate binds anti-integrase drugs. Proc Natl Acad Sci USA 106: 8192-8197.
28. Johnson AA, Santos W, Pais GC, Marchand C, Amin R, et al. (2006) Integration requires a specific interaction of the donor DNA terminal 5′-cytosine with glutamine 148 of the HIV-1 integrase flexible loop. J Biol Chem 281: 461-467.
29. Vera J, Valenzuela B, Roth MJ, Leon O, (2008) Characterization of the long-terminal repeat single-strand tail-binding site of Moloney-MuLV integrase by crosslinking. Biol Res 41: 69-80.
30. Harper AL, Skinner LM, Sudol M, Katzman M, (2001) Use of patient-derived human immunodeficiency virus type 1 integrases to identify a protein residue that affects target site selection. J Virol 75: 7756-7762.
31. Nowak MG, Sudol M, Lee NE, Konsavage WM, Katzman M, (2009) Identifying amino acid residues that contribute to the cellular-DNA binding site on retroviral integrase. Virol 389: 141-148.
32. Moreland RB, Smith PK, Fujimoto EK, Dockter ME, (1982) Synthesis and characterization of N-(4-azidophenylthio)phthalimide: A cleavable, photoactivable crosslinking reagent that reacts with sulfhydryl groups. Anal Biochem 121: 321-326.
33. Merkel G, Andrake MD, Ramcharan J, Skalka AM, (2009) Oligonucleotide-based assays for integrase activity. Methods 47: 243-248.
34. Kulinski J, Besack D, Oleykowski CA, Godwin AK, Yeung AT, (2000) CEL I enzymatic mutation detection assay. BioTechniques 29: 44-46.
35. Oleykowski CA, Bronson Mullins CR, Chang DW, Yeung AT, (1999) Incision at nucleotide insertions/deletions and base pair mismatches by the SP nuclease of spinach. Biochemistry 38: 2200-2205.
36. Oleykowski CA, Bronson Mullins CR, Godwin AK, Yeung AT, (1998) Mutation detection using a novel plant endonuclease. Nucleic Acids Res 26: 4597-4602.
37. Huang H, Chopra R, Verdine GL, Harrison SC, (1998) Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance. Science 282: 1669-1675.
38. Ellison V, Brown PO, (1994) A stable complex between integrase and viral DNA ends mediates human immunodeficiency virus integration in vitro. Proc Natl Acad Sci USA 91: 7316-7320.
39. Mazumder A, Uchida H, Neamati N, Sunder S, Jaworska-Maslanka M, et al. (1997) Probing interactions between viral DNA and human immunodeficiency virus type 1 integrase using dinucleotides. Mol Pharmacol 51: 567-575.
40. Miller MD, Farnet CM, Bushman FD, (1997) Human immunodeficiency virus type 1 preintegration complexes: studies of organization and composition. J Virol 71: 5382-5390.
41. Katz RA, DiCandeloro P, Kukolj G, Skalka AM, (2001) Role of DNA end distortion in catalysis by avian sarcoma virus integrase. J Biol Chem 276: 34213-34220.
42. Scottoline BP, Chow S, Ellison V, Brown PO, (1997) Disruption of the terminal base pairs of retroviral DNA during integration. Genes Dev 11: 371-382.
43. Renisio JG, Cosquer S, Cherrak I, El Antri S, Mauffret O, Fermandjian S, (2005) Pre-organized structure of viral DNA at the binding-processing site of HIV-1 integrase. Nucleic Acids Res 33: 1970-1981.
44. Katz RA, Merkel G, Andrake MD, Roder H, Skalka AM, (2011) Retroviral integrases promote fraying of viral DNA ends. J Biol Chem In press.
45. Bojja RS, Andrake MD, Weigand S, Merkel G, Yarychkivska O, et al. (2011) Architecture of a full-length retroviral integrase monomer and dimer, revealed by small angle X-ray scattering and chemical cross-linking. J Biol Chem 286: 17047-17059.
46. Lubkowski J, Yang F, Alexandratos J, Merkel G, Katz RA, et al. (1998) Structural basis for inactivating mutations and pH-dependent activity of avian sarcoma virus integrase. J Biol Chem 273: 32685-32689.
47. Lubkowski J, Dauter Z, Yang F, Alexandratos J, Merkel G, et al. (1999) Atomic resolution structures of the core domain of avian sarcoma virus integrase and its D64N mutant. Biochemistry 38: 13512-13522.
48. Zhao Z, McKee CJ, Kessl JJ, Santos WL, Daigle JE, et al. (2008) Subunit-specific protein footprinting reveals significant structural rearrangements and a role for N-terminal Lys-14 of HIV-1 Integrase during viral DNA binding. J Biol Chem 283: 5632-5641.
49. Dirac AM, Kjems J, (2001) Mapping DNA-binding sites of HIV-1 integrase by protein footprinting. Eur J Biochem 268: 743-751.
50. Michel F, Crucifix C, Granger F, Eiler S, Mouscadet JF, et al. (2009) Structural basis for HIV-1 DNA integration in the human genome, role of the LEDGF/P75 cofactor. EMBO J 28: 980-991.
51. Hobaika Z, Zargarian L, Boulard Y, Maroun RG, Mauffret O, et al. (2009) Specificity of LTR DNA recognition by a peptide mimicking the HIV-1 integrase α4 helix. Nucleic Acids Res 37: 7691-7700.
52. Erlanson DA, Chen L, Verdine GL, (1993) Allosteric effects on enzyme action in disulfide-crosslinked DNA. J Am Chem Soc 115: 12583-12584.
53. Yang B, Wen X, Kodali NS, Oleykowski CA, Miller CG, et al. (2000) Purification, cloning, and characterization of the CEL I nuclease. Biochemistry 39: 3533-3541.
54. Jenkins TM, Engelman A, Ghirlando R, Craigie R, (1996) A soluble active mutant of HIV-1 integrase: involvement of both the core and carboxyl-terminal domains in multimerization. J Biol Chem 271: 7712-7718.
55. Lutzke RA, Plasterk RH, (1998) Structure-based mutational analysis of the C-terminal DNA-binding domain of human immunodeficiency virus type 1 integrase: critical residues for protein oligomerization and DNA binding. J Virol 72: 4841-4848.